Early discoveries of CLU upregulation in AD patients [20], its ability to interact with Aβ [10], and strong genetic association of the CLU variants with AD risk [8, 9], have fueled subsequent studies focusing on the mechanism underlying the CLU contribution to AD pathogenesis. Here, CLU is linked to Alzheimer disease.